4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Ironwood Pharmaceuticals, Inc. (IRWD) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Boston, United States with about 100 employees. Its market capitalization is roughly $635 million. In the fiscal year ended 2025-12-31, IRWD reported $296M in revenue and $24M in net income.
Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.
Interactive charts & full statements → Open the IRWD valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $296M | $351M | $443M | $411M | — |
| Gross Profit | — | — | — | $411M | $414M |
| Operating Income (EBIT) | $119M | $96M | $168M | $250M | — |
| Net Income | $24M | $1M | ($1.0B) | $175M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $106M | $48M | $122M | $85M | $41M | — |
| Operating Income (EBIT) | $72M | $7M | $78M | $45M | ($10M) | — |
| Net Income | $41M | ($2M) | $40M | $24M | ($37M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $397M | $351M | $471M | $1.1B | — |
| Total Liabilities | $659M | $652M | $817M | $448M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IRWD viewer.
About TickerBase · Data methodology & sources